Prothena | PRTA - Resultado Líquido





Resultado Líquido Alterar Data
Acadia Pharmaceuticals USD 53.52M 22.02M 2026-09
Agios Pharmaceuticals USD -100.7M 1.59M 2026-06
Akebia Therapeutics USD -12.24M 12.78M 2025-12
ALKERMES USD 16.29M 15.79M 2026-09
Alnylam Pharmaceuticals USD 2.17B 2B 2026-09
Amgen USD 3.86B 1.49B 2026-09
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD -122.83M 167.59M 2026-09
Exelixis USD 218.1M 6.04M 2026-09
Immunic USD -19.3M 6.28M 2025-12
Incyte USD -784.8M 1.37B 2026-09
Ionis Pharmaceuticals USD -87M 27.65M 2026-09
MacroGenics USD 19.52M 56.29M 2026-06
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Neurocrine Biosciences USD 206.5M 62.1M 2026-09
Prothena USD -18.58M 51.3M 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Ultragenyx Pharmaceutical USD -118M 26M 2026-09
Vertex Pharmaceuticals USD 653.6M 446.2M 2026-09